Sunshine Biopharma Inc (SBFM)
0.93
+0.04
(+4.49%)
USD |
NASDAQ |
May 17, 16:00
0.92
-0.01
(-1.08%)
After-Hours: 20:00
Sunshine Biopharma 1 Year Total Returns (Daily): -98.37% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -98.37% |
May 16, 2024 | -98.44% |
May 15, 2024 | -98.58% |
May 14, 2024 | -98.77% |
May 13, 2024 | -98.81% |
May 10, 2024 | -98.32% |
May 09, 2024 | -98.27% |
May 08, 2024 | -98.03% |
May 07, 2024 | -98.07% |
May 06, 2024 | -98.13% |
May 03, 2024 | -98.59% |
May 02, 2024 | -98.58% |
May 01, 2024 | -98.54% |
April 30, 2024 | -98.60% |
April 29, 2024 | -98.63% |
April 26, 2024 | -98.49% |
April 25, 2024 | -98.76% |
April 24, 2024 | -98.61% |
April 23, 2024 | -98.19% |
April 22, 2024 | -97.85% |
April 19, 2024 | -97.48% |
April 18, 2024 | -95.12% |
April 17, 2024 | -94.49% |
April 16, 2024 | -90.00% |
April 15, 2024 | -91.01% |
Date | Value |
---|---|
April 12, 2024 | -87.29% |
April 11, 2024 | -86.60% |
April 10, 2024 | -85.25% |
April 09, 2024 | -85.68% |
April 08, 2024 | -85.49% |
April 05, 2024 | -84.95% |
April 04, 2024 | -85.22% |
April 03, 2024 | -84.05% |
April 02, 2024 | -88.79% |
April 01, 2024 | -85.43% |
March 28, 2024 | -91.60% |
March 27, 2024 | -92.67% |
March 26, 2024 | -92.68% |
March 25, 2024 | -92.62% |
March 22, 2024 | -92.56% |
March 21, 2024 | -92.50% |
March 20, 2024 | -92.82% |
March 19, 2024 | -93.41% |
March 18, 2024 | -93.59% |
March 15, 2024 | -92.46% |
March 14, 2024 | -94.05% |
March 13, 2024 | -93.89% |
March 12, 2024 | -93.90% |
March 11, 2024 | -93.39% |
March 08, 2024 | -93.45% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.91%
Minimum
Feb 09 2022
16.03K%
Maximum
May 25 2021
398.9%
Average
-79.70%
Median
May 05 2023
1 Year Total Returns (Daily) Benchmarks
Lexaria Bioscience Corp | 326.5% |
Acasti Pharma Inc | -10.35% |
Aurinia Pharmaceuticals Inc | -46.22% |
Edesa Biotech Inc | -30.85% |
Xenon Pharmaceuticals Inc | -3.66% |